153 related articles for article (PubMed ID: 8659446)
1. Malignant meningioma: a clinicopathologic study of 23 patients including MIB1 and p53 immunohistochemistry.
Prayson RA
Am J Clin Pathol; 1996 Jun; 105(6):719-26. PubMed ID: 8659446
[TBL] [Abstract][Full Text] [Related]
2. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.
Abramovich CM; Prayson RA
Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827
[TBL] [Abstract][Full Text] [Related]
3. Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas.
Abramovich CM; Prayson RA
Arch Pathol Lab Med; 1999 Sep; 123(9):793-800. PubMed ID: 10458826
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry.
Schwimer CJ; Prayson RA
Ann Diagn Pathol; 2001 Jun; 5(3):148-54. PubMed ID: 11436168
[TBL] [Abstract][Full Text] [Related]
5. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
[TBL] [Abstract][Full Text] [Related]
6. Proliferation and DNA fragmentation in meningioma subtypes.
Maier H; Wanschitz J; Sedivy R; Rössler K; Ofner D; Budka H
Neuropathol Appl Neurobiol; 1997 Dec; 23(6):496-506. PubMed ID: 9460716
[TBL] [Abstract][Full Text] [Related]
7. MIB1 and p53 immunoreactivity in protoplasmic astrocytomas.
Prayson RA; Estes ML
Pathol Int; 1996 Nov; 46(11):862-6. PubMed ID: 8970195
[TBL] [Abstract][Full Text] [Related]
8. [Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations].
Taddei GL; Caldarella A; Raspollini MR; Taddei A; Buccoliero AM
Pathologica; 2002 Feb; 94(1):10-5. PubMed ID: 11912872
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas.
Perry A; Stafford SL; Scheithauer BW; Suman VJ; Lohse CM
Cancer; 1998 Jun; 82(11):2262-9. PubMed ID: 9610708
[TBL] [Abstract][Full Text] [Related]
10. Meningioangiomatosis. A clinicopathologic study including MIB1 immunoreactivity.
Prayson RA
Arch Pathol Lab Med; 1995 Nov; 119(11):1061-4. PubMed ID: 7487408
[TBL] [Abstract][Full Text] [Related]
11. MIB-1 staining index of pediatric meningiomas.
Sandberg DI; Edgar MA; Resch L; Rutka JT; Becker LE; Souweidane MM
Neurosurgery; 2001 Mar; 48(3):590-5; discussion 595-7. PubMed ID: 11270550
[TBL] [Abstract][Full Text] [Related]
12. Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence.
Csonka T; Murnyák B; Szepesi R; Bencze J; Bognár L; Klekner A; Hortobágyi T
Folia Neuropathol; 2016; 54(2):114-26. PubMed ID: 27543769
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas.
Karamitopoulou E; Perentes E; Tolnay M; Probst A
Hum Pathol; 1998 Feb; 29(2):140-5. PubMed ID: 9490273
[TBL] [Abstract][Full Text] [Related]
14. MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management.
Ohta M; Iwaki T; Kitamoto T; Takeshita I; Tateishi J; Fukui M
Cancer; 1994 Dec; 74(12):3176-89. PubMed ID: 7982181
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of erbB-2 and p53 protein expression in benign and atypical human meningiomas.
Chozick BS; Benzil DL; Stopa EG; Pezzullo JC; Knuckey NW; Epstein MH; Finkelstein SD; Finch PW
J Neurooncol; 1996 Feb; 27(2):117-26. PubMed ID: 8699233
[TBL] [Abstract][Full Text] [Related]
16. The significance of immunohistochemical expression of Ki-67, p53, p21, and p16 in meningiomas tissue arrays.
Terzi A; Saglam EA; Barak A; Soylemezoglu F
Pathol Res Pract; 2008; 204(5):305-14. PubMed ID: 18374497
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome.
Korshunov A; Shishkina L; Golanov A
Int J Cancer; 2003 May; 104(6):728-34. PubMed ID: 12640680
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of proliferative indices in meningiomas.
Hsu DW; Pardo FS; Efird JT; Linggood RM; Hedley-Whyte ET
J Neuropathol Exp Neurol; 1994 May; 53(3):247-55. PubMed ID: 7909837
[TBL] [Abstract][Full Text] [Related]
19. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
[TBL] [Abstract][Full Text] [Related]
20. Cellular proliferation and nuclear ploidy assessments augment established prognostic factors in predicting malignancy in testicular Leydig cell tumours.
McCluggage WG; Shanks JH; Arthur K; Banerjee SS
Histopathology; 1998 Oct; 33(4):361-8. PubMed ID: 9822927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]